BioRender-Vorlage

The New Male Contraceptive Pill? A promising compound: YCT529

Erstellt von

Sally Kim

•

BioRender Team

Diese Vorlage verwenden – Kostenlos

Für die Registrierung ist keine Kreditkarte erforderlich.

Diese Vorlage ist in BioRender vollständig bearbeitbar

Tauschen Sie Text, Formen und Icons einfach aus
Jedes Icon, jede Linie und jedes Label lässt sich umfärben und neu anordnen
Exportieren oder teilen für jeden Anwendungszweck

Schließen Sie sich über 4 Millionen Wissenschaftlern an, die bereits publikationsreife Abbildungen erstellen

Description: Currently there are only a limited number of effective birth control options for males, although many exist for females. Scientists have now reported that a compound named YCT529 may act as an effective non-hormonal male contraceptive. In preclinical trials, YCT529 was able to effectively prevent pregnancy when given orally daily to male mice. When the treatment was stopped male mice were fertile again after 4-6 weeks, proving YCT529 to be a potential reversible male contraceptive. Given its effectiveness in mice, clinical trials of YCT529 are in preparation. If proven safe and effective in humans, YCT529 may provide an attractive alternative to other male contraceptive methods.

BioRender-Icons und -Vorlagen entsprechen den Standards für Fachzeitschriften, Förderanträge und Urheberrechte. Bei KI-generierten Abbildungen variieren die Richtlinien. Mehr erfahren

Nicht die passende Vorlage gefunden? Entdecken Sie mehr.

Durchsuchen Sie Tausende von Vorlagen aus über 30 Bereichen der Biowissenschaften.

Beliebte Themen:

Cell

Krebs

Wirkstofffreisetzung

Wirkmechanismus

Signalweg

Versuchen Sie es mit einem Synonym oder registrieren Sie sich, um in der App eine Vorlage vorzuschlagen.

Neueste Vorlagen

AAV Production by Triple Transfection

His-tagged Protein Purification

MHC-Associated Peptide Proteomics (MAPPs)

ChIP sequencing

How Soap Kills COVID-19

Direct ELISA

Whole Genome Sequencing

Restriction Enzymes Cloning

BioRender-Vorlagen-FAQs

What does the The New Male Contraceptive Pill? A promising compound: YCT529 template show?

Currently there are only a limited number of effective birth control options for males, although many exist for females. Scientists have now reported that a compound named YCT529 may act as an effective non-hormonal male contraceptive. In preclinical trials, YCT529 was able to effectively prevent pregnancy when given orally daily to male mice. When the treatment was stopped male mice were fertile again after 4-6 weeks, proving YCT529 to be a potential reversible male contraceptive. Given its effectiveness in mice, clinical trials of YCT529 are in preparation. If proven safe and effective in humans, YCT529 may provide an attractive alternative to other male contraceptive methods.

Is the The New Male Contraceptive Pill? A promising compound: YCT529 template free to use?

Yes, you can customize this template with a free BioRender account (no credit card required). Paid plans unlock additional export formats, higher-resolution downloads, and publication permissions.

Can I edit or customize this template?

Yes, every element is fully editable. Icons, labels, colors, arrows, shapes and layout can all be changed to match your preferences or needs using BioRender's drag-and-drop editor. You can add or remove elements to fully customize your use case.

Is this template accepted for use in journals, theses, or grant applications?

Yes, BioRender icons and templates meet journal, grant, and copyright standards for publication, and many researchers cite BioRender directly in their figure legends.

How do I cite BioRender if I use this template?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

What is The New Male Contraceptive Pill? A promising compound: YCT529 used for / who typically uses this template?

Researchers and scientists use this template for publications, funding proposals, grant applications, presentations, posters, and more.